A Study of the Relationship Between Fetal (Pre-birth Infant) DNA and the Maternal Immune Response

Overview

Información sobre este estudio

The purpose of this study is to learn the relationship between fetal (pre-birth infant) DNA and the mother's immune system. Fetal DNA can be found in the Mother's blood as early as 4 weeks after conception. The study wants to know if high levels of fetal DNA cause a maternal immune response that leads to problems like preterm birth.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

 Inclusion Criteria

  • Age ≥18 and ≤35 years at study entry
  • Healthy women 
  • First pregnancy (to eliminate any potential confusion related to alterations in immunity that may remain from previous pregnancies)
  • No known pregnancy complications at the first obstetrics visit (uncomplicated pregnancy)
  • Ability to provide written informed consent.
  • Weight greater than 110 pounds (50 kilograms, a standard requirement in obstetrics studies that include blood draws).

 Exclusion Criteria

  • Known immunodeficiency.
  • Chronic, active viral infections, including HIV-1/2, HTLV-1/2, hepatitis B/C.
  • Known autoimmune disease (e.g., rheumatoid arthritis or systemic lupus erythematosus).
  • Solid organ or transplant recipient.
  • Prior pregnancy termination or known miscarriage.
  • Current smokers (tobacco exposure within 30 days of registration).
  • Conceptions from assisted reproductive technology.  Prior Clomid® use is allowed.
  • Multiple gestations.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Elizabeth Ann Enninga, Ph.D.

Cerrado para la inscripción

Contact information:

Angela Sivly CCRP

(507) 266-1734

Sivly.Angela@mayo.edu

More information

Publicaciones

Publications are currently not available
.
CLS-20169924

Mayo Clinic Footer